Pharmacological actions of cathecholamines

Slides:



Advertisements
Similar presentations
Sympathetic Drugs. Stress and The Adrenal Glands.
Advertisements

Basic introduction to systemic hypertension
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 13 Physiology of the Peripheral Nervous System.
PHARMACOLOGY OF SNS.
Drugs Affecting Peripheral Nervous System #2. Fight or Flight versus the Parasympathetic Pig.
Pharmacology-1 PHL 211 Thirteenth Lecture By Abdelkader Ashour, Ph.D. Phone:
Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
SYMPATHETIC NERVOUS SYTEM
Chapter 5 Autonomic Drugs.
Heart control DR. HANA OMER.
Regulating Systems Week 3 Dr. Walid Daoud As. Professor.
ADRENERGIC ANTAGONITS
Basic introduction to CVS diseases By Dr. MOHAMED ABD ALMONEIM ATTIA.
Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab.DCA, Dip. Software statistics- Ph d Mahatma Gandhi Medical college and research institute, puducherry,
ADRENERGIC RECEPTORS AND DRUGS
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
Sympathomimetics (continue)
SYMPATHOMIMETICS Classification: A- According to the source:
Vasopressors.
Adrenergic agonists Samuel Aguazim (MD).
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. LECTURE 10 Sympathatic nervous system.
The Peripheral Nervous System The Autonomic Motor Division of the PNS is called the ANS (autonomic nervous system) –Contains two divisions Sympathetic.
Chapter 33 Agents Affecting the Autonomic Nervous System.
1 Adrenergic Receptor Agonists Termed sympathomimetic drugs Divided into three groups Direct-acting agonists –Catecholamines –Noncatecholamines Indirect-acting.
Chapter 19 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
1 A N S  NERVOUS SYSTEM  PNS CNS   EFFERENT AFFERENT   ANS SOMATIC  ENTERIC  PARASYMPATHETIC  SYMPATHETIC.
Physiology of Adrenal Medulla Dr. Eman El Eter. A case study? “Rollie Hendrix,” a 35-year-old husband and father of three children, has been experiencing.
Sympathetic Nervous System Needed for studying SNS PHARMACOLOGY
 Differ in: Site of ganglia Length of pre & postganglionic fiber Mediators of postganglionic fiber Ramifies adrenal medulla and its mediator circulate.
Adrenal (Suprarenal )Medulla Dr Taha Sadig Ahmed.
Sympathomimetic Agents
Sympathetic Nervous System Needed for studying SNS PHARMACOLOGY
Part 4 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
Actions of epinephrine:
Lecture 11b Clinical uses of adrenergic agonists.
23 كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، 1623 كانون الثاني، كانون الثاني، كانون الثاني،
Lecture 7 Summary –Adrenalin (α & β): ↑ systolic BP & slight ↓diastolic BP –NA: (α & β1) ↑ systolic & diastolic BP + Reflex bradycardia –Isoproterenol.
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Adrenergic agonists Saja Hamed, Ph.D.
Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF ANS part 2 General Pharmacology M212.
Adrenal (Suprarenal )Medulla Dr Taha Sadig Ahmed.
Endocrine Physiology The Adrenal Medulla, Pheochromocytoma Dr. Khalid Alregaiey.
Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. 1 Chapter 18 ADRENERGIC AGONISTS AND ADRENERGIC BLOCKERS.
SYMPATHOMIMETIC AGENTS
Comparison of somatic and autonomic systems Targets – Somatic = skeletal muscle – Autonomic = smooth/cardiac muscle & glands Efferent pathways – Somatic.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenoceptors  The adrenergic receptors are classified into Two categories:
M.Prasad Naidu MSc Medical Biochemistry, Ph.D.Research Scholar.
1 Parasympathetic NS (craniosacral) Preganglionic neurons………………………. Cranial outflow…. - occulomotor (III) - facial (VII) - glossopharyngeal (IX) - vagus.
Adrenergic Antagonists
Dr Asma Jabeen Assistant professor, Physiology Transmission in ANS(Catecholamines)
Department of Pharmacology
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
ADRENERGIC MEDICATIONS (sympathomimetic drugs)
Antimuscarinic Agents
Adrenergic Agonists Produce their effects by activating adrenergic receptors Adrenergic receptors are Alpha 1 Alpha 2 Beta 1 Beta 2 Dopamine.
Type of adrenergic receptor
School of Pharmacy, University of Nizwa
Chapter 5 Autonomic Drugs.
Adrenergic agonists.
Characteristics of Adrenergic Drugs (p. 291)
Adrenergic [ædrə‘nədʒik] agonists
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
Adrenergic agonists and antagonists
Adrenergic Acting Drugs Pharmaceutical Medicinal Chemistry-I
Adrenergic System And Drugs  Adrenergic transmission  Adrenergic receptor  Adrenergic drugs  Therapeutic classification of adrenergic drugs  Pharmacological.
SNS Drugs Anita Bolina 23rd March 2019.
Sympathomimetics or Adrenergic Drugs
Adrenergic agonists ILOS
Vasoconstrictors Originally added to reduce systemic uptake in an attempt to limit toxicity. Prolong the duration Produces profound anaesthesia. Reduce.
Presentation transcript:

Pharmacological actions of cathecholamines Dr Adedunni Olusanya

Objectives Identify cathecholamines Understand their mechanism of actions

Cathecholamine -Intro Made up of a benzene ring Linked to 2 hydroxyl group and an amine group Includes dopamine, norepinephrine and epinephrine Same synthetic pathway – tyrosine is the precursor

Cathecholamines Dopamine – a precursor of other cathecholamine, synthesised in the cytoplasm and stored in vesicles or converted to NE NE – synthesised and stored in vesicles and adsorbed on chromagrannin as a complex with ATP Adrenalin – formed from NE by glucocorticoid induction of N- methyltransferase in the adrenal medulla. NE diffuses into the cytoplasm where it is converted to Adr by the methylating enzyme

Pharmacokinetics Orally inactive Rapidly metabolized by MAO and COMT in the intestinal wall and the liver – very low bioavailability Hence given parenterally

Dopamine Precursor of other naturally occurring catecholamine Major neurotransmitter in the basal ganglia, limbic system, chemoreceptor trigger zone and other parts of the CNS Peripherally acts on renal and mesenteric endothelium

Dopamine (contd) Agonist at D1, D2, A1 and B1 receptors Main effect is on vascular tissue A1 adrenergic receptors - vasoconstriction at high doses B1 and D1 receptor - positive inotropic effect D 1 receptor- dilation of renal and mesenteric vessels

Blood pressure - increases systolic BP No effect on diastolic BP

Clinical uses Severe heart failure To increase BP and urine outflow

Adrenaline Heart - Increases heart rate, conduction and contraction via beta 1 Blood vessel – Vasoconstriction in cutaneous, mucous membrane and renal bed via alpha 1 Dilation in skeletal muscles, livers and coronary vessels via beta 2 No direct effect on cerebral blood vessel Blood pressure Increase in systolic BP Decrease in diastolic blood pressure Decrease in peripheral resistance A moderate increase in mean BP

Adrenalin Respiration Git and bladder Bronchodilation via beta 2 Decongestant on bronchial muscle via alpha one Git and bladder Relaxation of smooth muscles – alpha 1, beta 2 , constriction of sphincters- Alpha 1 Uterus – Relaxation B2 Contraction – Alpha 1

Adrenalin contd Skeletal muscle – Metabolic effects – Adrenalin augments Ach release via alpha 1 receptors (heteroceptors). On muscle fibres – B2 shortens the active phase of contraction and reduced tension is developed in the slow contracting red fibres as well as increased firing of muscle spindles – tremors. Metabolic effects – glycogenolysis leading to hyperglycaemia in the liver - B2 , muscle glycogenolysis leading to hyperlacticidaemia – B2 Fats lipolysis – B1, B2 , B3 Mild effect on insulin secretion – B2 Renin increase via B1

Adverse effects and contraindications Transient restlessness, tremors, anxiety, tremors and pallor Transient hypertension Contraindicated in hypertensive, hyperthyroid and angina patients Contraindicated with halothane use – arrhythmia Contraindicated in patients on Beta blockers- dangerous hypertensive crises may develop because of unopposed alpha blockade

Clinical uses Cardiac stimulant Local vasoconstrictor

Noradrenaline Similar to adrenalin but because of its very low to absent effect on B2 , some differences Blood pressure – Increases both systolic and diastolic , Increased peripheral resistance and mean arterial BP Reduce heart rate – Causes higher blood pressure hence more likely to cause vagal stimulation. Blood vessels – reduced blood flow due to A1 effect on skeletal, skin and mucous membrane and renal vessels No effect on bronchial smooth muscle, GIT, Bladder – relaxation of muscle, contraction of trigone Metabolic effects – insulin secretion inhibited by A 2

Clinical uses of noradrenaline Rarely used